Ultromics Revenue and Competitors

Oxford, UK

Location

$58.8M

Total Funding

Estimated Revenue & Valuation

  • Ultromics's estimated annual revenue is currently $9M per year.(i)
  • Ultromics's estimated revenue per employee is $121,800
  • Ultromics's total funding is $58.8M.

Employee Data

  • Ultromics has 74 Employees.(i)
  • Ultromics grew their employee count by -6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$244.2M1097-20%$1.1BN/A
#2
$30.3M197-25%N/AN/A
#3
$2.4M24-33%N/AN/A
#4
$14.8M10638%N/AN/A
#5
$4.5M4011%$2MN/A
#6
$0M3-40%$184MN/A
#7
$18.1M129-41%N/AN/A
#8
$11.8M84-12%N/AN/A
#9
$77.5M4437%N/AN/A
#10
$32.5M21113%N/AN/A
Add Company

Ultromics is a global health technology company which provides autonomous echocardiography analysis through innovative AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. Our cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site. Our aim is to save clinicians time and allow them to confidently make diagnostic decisions. We are helping healthcare providers streamline care, increase productivity and improve patient outcomes whilst also allowing them to make valuable resource and cost savings. For more information about Ultromics visit http://www.ultromics.com/

keywords:N/A

$58.8M

Total Funding

74

Number of Employees

$9M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ultromics News

2021-08-17 - Ultromics Raises $33M in Series B Funding

Ultromics, an Oxford, UK-based company focused on advancing AI enabled cardiovascular imaging solutions, raised $33M in series B funding. The round was led by Blue Venture Fund with participation from Optum Ventures, GV and Oxford Sciences Innovation. The company intends to use the funds to ac ...

2021-08-16 - Ultromics racks up $33M to drive its cardiac ultrasound AI software

After netting an FDA clearance at the top of this year for its artificial intelligence-powered ultrasound system designed to help spot dangerous blockages in the heart’s coronary arteries, Ultromics has secured $33 million in funding to help boost its adoption in hospitals. RELATED: ACC 2021 | ...

2021-08-16 - UK-based Ultromics raises €28M to help clinicians diagnose heart disease using AI; here’s how

Oxford, UK-based Ultromics is a healthtech company that provides autonomous echocardiography analysis through Artificial Intelligence (AI) solutions. Echocardiography is a test that uses sound waves to produce live images of your heart – the image is called an echocardiogram. This test allows do ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.8M75-4%N/A
#2
$16.4M751%N/A
#3
$20.5M769%N/A
#4
$16.7M7613%N/A
#5
$7.5M760%N/A